Review Article

You have full text access to this OnlineOpen article

Psychiatric disorders in advanced cancer

  1. Michael Miovic MD*,
  2. Susan Block MD

Article first published online: 10 SEP 2007

DOI: 10.1002/cncr.22980

Issue

Cancer

Cancer

Volume 110, Issue 8, pages 1665–1676, 15 October 2007

Additional Information

How to Cite

Miovic, M. and Block, S. (2007), Psychiatric disorders in advanced cancer. Cancer, 110: 1665–1676. doi: 10.1002/cncr.22980

Author Information

  1. Division of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School Center for Palliative Care, Boston, Massachusetts

*Psychosocial Oncology, G-442B, Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115

Publication History

  1. Issue published online: 19 SEP 2007
  2. Article first published online: 10 SEP 2007
  3. Manuscript Accepted: 7 MAY 2007
  4. Manuscript Received: 23 APR 2007

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (141K)

REFERENCES

  • 1
    Van der Lee ML,Swarte NB,Van der Bom JG,Van den Bout J,Heintz AP. Positive feelings among terminally ill cancer patients. Eur J Cancer Care (Engl). 2006; 15: 51–55.
    Direct Link:
  • 2
    Lloyd-Williams M. How common are thoughts of self-harm in a UK palliative care population? Support Care Cancer. 2002; 10: 422–424.
  • 3
    Grabsch B,Clarke DM,Love A, et al. Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey. Palliat Support Care. 2006; 4: 47–56.
  • 4
    Kissane DW,Grabsch B,Love A,Clarke DM,Bloch S,Smith GC. Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry. 2004; 38: 320–326.
    Direct Link:
  • 5
    Kugaya A,Akechi T,Okuyama T, et al. Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer. 2000; 88: 2817–2823.
    Direct Link:
  • 6
    Wilson KG,Chochinov HM,Skirko MG, et al. Depression and anxiety disorders in palliative cancer care. J Pain Symptom Manage. 2007; 33: 118–129.
  • 7
    Passik SD,Dugan W,McDonald MV,Rosenfeld B,Theobald DE,Edgerton S. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol. 1998; 16: 1594–1600.
  • 8
    Sollner W,DeVries A,Steixner E, et al. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer. 2001; 84: 179–185.
  • 9
    O'Mahony S,Goulet J,Kornblith A, et al. Desire for hastened death, cancer pain and depression: report of a longitudinal observational study. J Pain Symptom Manage. 2005; 29: 446–457.
  • 10
    Block SD. Psychological issues in end-of-life care. J Palliat Med. 2006; 9: 751–772.
  • 11
    Kirsh KL,McGrew JH,Dugan M,Passik SD. Difficulties in screening for adjustment disorder, Part I: Use of existing screening instruments in cancer patients undergoing bone marrow transplantation. Palliat Support Care. 2004; 2: 23–31.
  • 12
    Kadan-Lottick NS,Vanderwerker LC,Block SD,Zhang B,Prigerson HG. Psychiatric disorders and mental health service use in patients with advanced cancer: a report from the coping with cancer study. Cancer. 2005; 104: 2872–2881.
    Direct Link:
  • 13
    Hotopf M,Chidgey J,Addington-Hall J,Ly KL. Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med. 2002; 16: 81–97.
  • 14
    Prieto JM,Blanch J,Atala J, et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002; 20: 1907–1917.
  • 15
    Akechi T,Okamura H,Nishiwaki Y,Uchitomi Y. Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma: a longitudinal study. Cancer. 2001; 92: 2609–2622.
    Direct Link:
  • 16
    Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
  • 17
    Clarke DM,Kissane DW. Demoralization: its phenomenology and importance. Aust N Z J Psychiatry. 2002; 36: 733–742.
    Direct Link:
  • 18
    Mangelli L,Fava GA,Grandi S, et al. Assessing demoralization and depression in the setting of medical disease. JClin Psychiatry. 2005; 66: 391–394.
  • 19
    Mystakidou K,Tsilika E,Parpa E,Katsouda E,Galanos A,Vlahos L. Psychological distress of patients with advanced cancer: influence and contribution of pain severity and pain interference. Cancer Nurs. 2006; 29: 400–405.
  • 20
    Roth A,Nelson CJ,Rosenfeld B, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics. 2006; 47: 340–347.
  • 21
    Lloyd-Williams M,Friedman T,Rudd N. An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage. 2001; 22: 990–996.
  • 22
    Mystakidou K,Tsilika E,Parpa E,Katsouda E,Galanos A,Vlahos L. The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability. Support Care Cancer. 2004; 12: 821–825.
  • 23
    Akechi T,Okuyama T,Sugawara Y,Shima Y,Furukawa TA,Uchitomi Y. Screening for depression in terminally ill cancer patients in Japan. J Pain Symptom Manage. 2006; 31: 5–12.
  • 24
    Holland JC,Morrow GR,Schmale A, et al. A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol. 1991; 9: 1004–1011.
  • 25
    Razavi D,Kormoss N,Collard A,Farvacques C,Delvaux N. Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study. J Int Med Research. 1999; 27: 264–272.
  • 26
    Pugliese P,Perrone M,Nisi E, et al. An integrated psychological strategy for advanced colorectal cancer patients. Health Qual Life Outcomes. 2006; 4: 9.
  • 27
    Kornblith AB,Dowell JM,Herndon JE2nd, et al. Telephone monitoring of distress in patients aged 65 years or older with advanced stage cancer: a cancer and leukemia group B study. Cancer. 2006; 107: 2706–2714.
    Direct Link:
  • 28
    Spiegel D,Bloom JR,Yalom I. Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiatry. 1981; 38: 527–533.
  • 29
    Goodwin PJ,Leszcz M,Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001; 345: 1719–1726.
  • 30
    Classen C,Butler LD,Koopman C, et al. Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry. 2001; 58: 494–501.
  • 31
    Edwards AG,Hailey S,Maxwell M. Psychological interventions for women with metastatic breast cancer. Cochrane Database Syst Rev. 2004:CD004253. Comment in:Evid Based Nurs.2004; 7: 110.
  • 32
    Potash M,Breitbart W. Affective disorders in advanced cancer. Hematol Oncol Clin North Am. 2002; 16: 671–700.
  • 33
    Barsevick AM,Dudley WN,Beck SL. Cancer-related fatigue, depressive symptoms, and functional status: a mediation model. Nurs Res. 2006; 55: 366–372.
  • 34
    Raison CL,Miller AH. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry. 2003; 54: 283–294.
  • 35
    Illman J,Corringham R,Robinson DJr, et al. Are inflammatory cytokines the common link between cancer-associated cachexia and depression?. J Support Oncol. 2005; 3: 37–50. Comments in:J Support Oncol.2005;3:51–52;J Support Oncol.2005;3:55–57.
  • 36
    McDaniel JS,Musselman DL,Porter MR,Reed DA,Nemeroff CB. Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry. 1995; 52: 89–99.
  • 37
    Skarstein J,Bjelland I,Dahl AA,Laading J,Fossa SD. Is there an association between haemoglobin, depression, and anxiety in cancer patients? J Psychosom Res. 2005; 58: 477–483.
  • 38
    Mainio A,Hakko H,Niemela A,Koivukangas J,Rasanen P. Depression and functional outcome in patients with brain tumors: a population-based 1-year follow-up study. J Neurosurg. 2005; 103: 841–847.
  • 39
    Pirl WF,Siegel GI,Goode MJ,Smith MR. Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study. Psychooncology. 2002; 11: 518–523.
    Direct Link:
  • 40
    Stommel M,Given BA,Given CW. Depression and functional status as predictors of death among cancer patients. Cancer. 2002; 94: 2719–2727.
    Direct Link:
  • 41
    Loberiza FRJr,Rizzo JD,Bredeson CN, et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002; 20: 2118–2126.
  • 42
    Mainio A,Hakko H,Timonen M,Niemela A,Koivukangas J,Rasanen P. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery. 2005; 56: 1234–1241; discussion 1241–1242.
  • 43
    Faller H,Bulzebruck H,Drings P,Lang H. Coping, distress, and survival among patients with lung cancer. Arch Gen Psychiatry. 1999; 56: 756–762.
  • 44
    Nakaya N,Saito-Nakaya K,Akizuki N, et al. Depression and survival in patients with non-small cell lung cancer after curative resection: a preliminary study. Cancer Sci. 2006; 97: 199–205.
    Direct Link:
  • 45
    Breitbart W,Bruera E,Chochinov H,Lynch M. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symptom Manage. 1995; 10: 131–141.
  • 46
    Pelletier G,Verhoef MJ,Khatri N,Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 2002; 57: 41–49.
  • 47
    Chochinov HM,Wilson KG,Enns M, et al. Desire for death in the terminally ill. Am J Psychiatry. 1995; 152: 1185–1191.
  • 48
    van der Lee ML,van der Bom JG,Swarte NB,Heintz AP,de Graeff A,van den Bout J. Euthanasia and depression: a prospective cohort study among terminally ill cancer patients. J Clin Oncol. 2005; 23: 6607–6612. Comment in:J Clin Oncol.2006;24:3211–3212; author reply 3212–3213.
  • 49
    Emanuel EJ,Fairclough DL,Emanuel LL. Attitudes and desires related to euthanasia and physician-assisted suicide among terminally ill patients and their caregivers. JAMA. 2000; 284: 2460–2468.
  • 50
    Chochinov HM,Wilson KG,Enns M,Lander S. “Are you depressed?” Screening for depression in the terminally ill. Am J Psychiatry. 1997; 154: 674–676.
  • 51
    Lloyd-Williams M,Dennis M,Taylor F,Baker I. Is asking patients in palliative care, “are you depressed?” Appropriate? Prospective study. BMJ. 2003; 327: 372–373.
  • 52
    Block SD. Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel.American College of Physicians—American Society of Internal Medicine. Ann Intern Med. 2000; 132: 209–218.
  • 53
    van Heeringen K,Zivkov M. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin. Br J Psychiatry. 1996; 169: 440–443.
  • 54
    Morrow GR,Hickok JT,Roscoe JA, et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003; 21: 4635–4641.
  • 55
    Fisch MJ,Loehrer PJ,Kristeller J, et al. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol. 2003; 21: 1937–1943.
  • 56
    Pirl WF. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monographs. 2004: 32–39.
  • 57
    Meyers CA,Weitzner MA,Valentine AD,Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol. 1998; 16: 2522–2527.
  • 58
    Sood A,Barton DL,Loprinzi CL. Use of methylphenidate in patients with cancer. Am J Hosp Palliat Care. 2006; 23: 35–40.
  • 59
    Hanna A,Sledge G,Mayer ML, et al. A phase II study of methylphenidate for the treatment of fatigue. Support Care Cancer. 2006; 14: 210–215.
  • 60
    Dalton SO,Johansen C,Mellemkjaer L, et al. Antidepressant medications and risk for cancer. Epidemiology. 2000; 11: 171–176.
  • 61
    Gill D,Hatcher S. Antidepressants for depression in people with physical illness. Cochrane Database Syst Rev. 2000:CD001312. Update in:Cochrane Database Syst Rev.2000;(4):CD001312. PMID: 10796770.
  • 62
    Theobald DE,Kirsh KL,Holtsclaw E,Donaghy K,Passik SD. An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients. Palliat Support Care. 2003; 1: 71–77.
  • 63
    Dalton SO,Sorensen HT,Johansen C. SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing? CNS Drugs. 2006; 20: 143–151.
  • 64
    Theobald DE,Kirsh KL,Holtsclaw E,Donaghy K,Passik SD. An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J Pain Symptom Manage. 2002; 23: 442–447.
  • 65
    Cullum JL,Wojciechowski AE,Pelletier G,Simpson JS. Bupropion sustained release treatment reduces fatigue in cancer patients. Can J Psychiatry. 2004; 49: 139–144.
  • 66
    Foley KF,DeSanty KP,Kast RE. Bupropion: pharmacology and therapeutic applications. Expert Rev Neurother. 2006; 6: 1249–1265.
  • 67
    Williams S,Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review. Br J Cancer. 2006; 94: 372–390.
  • 68
    Sharpe M,Strong V,Allen K, et al. Management of major depression in outpatients attending a cancer centre: a preliminary evaluation of a multicomponent cancer nurse-delivered intervention. Br J Cancer. 2004; 90: 310–313.
  • 69
    Midtgaard J,Rorth M,Stelter R, et al. The impact of a multidimensional exercise program on self-reported anxiety and depression in cancer patients undergoing chemotherapy: a phase II study. Palliat Support Care. 2005; 3: 197–208.
  • 70
    Adamsen L,Quist M,Midtgaard J, et al. The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy. Support Care Cancer. 2006; 14: 116–127.
  • 71
    Cluver JS,Schuyler D,Frueh BC,Brescia F,Arana GW. Remote psychotherapy for terminally ill cancer patients. J Telemed Telecare. 2005; 11: 157–159.
  • 72
    Gurevich M,Devins GM,Rodin GM. Stress response syndromes and cancer: conceptual and assessment issues. Psychosomatics. 2002; 43: 259–281.
  • 73
    Pitman RK,Lanes DM,Williston SK, et al. Psychophysiologic assessment of posttraumatic stress disorder in breast cancer patients. Psychosomatics. 2001; 42: 133–140.
  • 74
    Derogatis LR,Morrow GR,Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983; 249: 751–757.
  • 75
    Stark D,Kiely M,Smith A,Velikova G,House A,Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol. 2002; 20: 3137–3148.
  • 76
    Roth AJ,Breitbart W. Psychiatric emergencies in terminally ill cancer patients. Hematol Oncol Clin North Am. 1996; 10: 235–259.
  • 77
    Butler LD,Koopman C,Classen C,Spiegel D. Traumatic stress, life events, and emotional support in women with metastatic breast cancer: cancer-related traumatic stress symptoms associated with past and current stressors. Health Psychol. 1999; 18: 555–560.
  • 78
    Kornblith AB,Herr HW,Ofman US,Scher HI,Holland JC. Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care. Cancer. 1994; 73: 2791–2802.
    Direct Link:
  • 79
    Stark D,Kiely M,Smith A,Morley S,Selby P,House A. Reassurance and the anxious cancer patient. Br J Cancer. 2004; 91: 893–899.
  • 80
    Hay JL,Passik SD. The cancer patient with borderline personality disorder: suggestions for symptom-focused management in the medical setting. Psychooncology. 2000; 9: 91–100.
    Direct Link:
  • 81
    Betan E,Heim AK,Zittel Conklin C,Westen D. Countertransference phenomena and personality pathology in clinical practice: an empirical investigation. Am J Psychiatry. 2005; 162: 890–898. Comment in:Am J Psychiatry.2005;162:833–835.
  • 82
    Chow E,Connolly R,Wong R, et al. Use of the CAGE questionnaire for screening problem drinking in an out-patient palliative radiotherapy clinic. J Pain Symptom Manage. 2001; 21: 491–497.
  • 83
    Bruera E,Neumann C,Brenneis C,Quan H. Frequency of symptom distress and poor prognostic indicators in palliative cancer patients admitted to a tertiary palliative care unit, hospices, and acute care hospitals. J Palliat Care. 2000; 16: 16–21.
  • 84
    Aertgeerts B,Buntinx F,Kester A. The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis. J Clin Epidemiol. 2004; 57: 30–39.
  • 85
    McCusker MT,Basquille J,Khwaja M,Murray-Lyon IM,Catalan J. Hazardous and harmful drinking: a comparison of the AUDIT and CAGE screening questionnaires. QJM. 2002; 95: 591–595.
  • 86
    Passik SD,Theobald DE. Managing addiction in advanced cancer patients: why bother? J Pain Symptom Manage. 2000; 19: 229–234.
  • 87
    Kirsh KL,Passik SD. Palliative care of the terminally ill drug addict. Cancer Invest. 2006; 24: 425–431.
  • 88
    Damjanovic A,Ivkovic M,Jasovic-Gasic M,Paunovic V. Comorbidity of schizophrenia and cancer: clinical recommendations for treatment. Psychiatr Danub. 2006; 18: 55–60.
  • 89
    Inagaki T,Yasukawa R,Okazaki S, et al. Factors disturbing treatment for cancer in patients with schizophrenia. Psychiatry Clin Neurosci. 2006; 60: 327–331.
    Direct Link:
  • 90
    Kilbourne AM,McCarthy JF,Welsh D,Blow F. Recognition of co-occurring medical conditions among patients with serious mental illness. J Nerv Ment Dis. 2006; 194: 598–602.
  • 91
    Foti ME,Bartels SJ,Van Citters AD,Merriman MP,Fletcher KE. End-of-life treatment preferences of persons with serious mental illness. Psychiatr Serv. 2005; 56: 585–591.
  • 92
    Foti ME,Bartels SJ,Merriman MP,Fletcher KE,Van Citters AD. Medical advance care planning for persons with serious mental illness. Psychiatr Serv. 2005; 56: 576–584.
  • 93
    Greenberg DB,Jonasch E,Gadd MA, et al. Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes. Cancer. 2000; 89: 356–362.
    Direct Link:
  • 94
    Brown RF,Butow PN,Henman M,Dunn SM,Boyle F,Tattersall MH. Responding to the active and passive patient: flexibility is the key. Health Expectations. 2002; 5: 236–245.
    Direct Link:
  • 95
    Travado L,Grassi L,Gil F,Ventura C,Martins C;Southern European Psycho-Oncology Study Group. Physician-patient communication among Southern European cancer physicians: the influence of psychosocial orientation and burnout. Psychooncology. 2005; 14: 661–670.
    Direct Link:
  • 96
    Fellowes D,Wilkinson S,Moore P. Communication skills training for health care professionals working with cancer patients, their families and/or carers. Cochrane Database Syst Rev. 2004:CD003751.
  • 97
    Jenkins V,Fallowfield L. Can communication skills training alter physicians' beliefs and behavior in clinics? J Clin Oncol. 2002; 20: 765–769.
  • 98
    Fallowfield L,Jenkins V,Farewell V,Solis-Trapala I. Enduring impact of communication skills training: results of a 12-month follow-up. Br J Cancer. 2003; 89: 1445–1459.
  • 99
    Hagerty RG,Butow PN,Ellis PM,Dimitry S,Tattersall MH. Communicating prognosis in cancer care: a systematic review of the literature. Ann Oncol. 2005; 16: 1005–1053.
  • 100
    Hagerty RG,Butow PN,Ellis PM, et al. Communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosis. J Clin Oncol. 2005; 23: 1278–1288. Erratum in:J Clin Oncol.2005;23:3652. Mac Leod, Craig [corrected to MacLeod, Craig].
  • 101
    Clayton JM,Butow PN,Tattersall MH. When and how to initiate discussion about prognosis and end-of-life issues with terminally ill patients. J Pain Symptom Manage. 2005; 30: 132–144.
  • 102
    Clayton JM,Butow PN,Tattersall MH. The needs of terminally ill cancer patients versus those of caregivers for information regarding prognosis and end-of-life issues. Cancer. 2005; 103: 1957–1964.
    Direct Link:
  • 103
    Clayton JM,Butow PN,Arnold RM,Tattersall MH. Discussing life expectancy with terminally ill cancer patients and their carers: a qualitative study. Support Care Cancer. 2005; 13: 733–742.
  • 104
    Clayton JM,Butow PN,Arnold RM,Tattersall MH. Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer. 2005; 103: 1965–1975.
    Direct Link:
  • 105
    McClain CS,Rosenfeld B,Breitbart W. Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients. Lancet. 2003; 361: 1603–167. Comment in:Lancet.2003;362:408.
  • 106
    Chochinov HM,Hack T,Hassard T,Kristjanson LJ,McClement S,Harlos M. Dignity therapy: a novel psychotherapeutic intervention for patients near the end of life. J Clin Oncol. 2005; 23: 5520–5525.
  • 107
    Breitbart W,Gibson C,Poppito SR,Berg A. Psychotherapeutic interventions at the end of life: a focus on meaning and spirituality. Can J Psychiatry. 2004; 49: 366–372.
  • 108
    Clayton JM,Butow PN,Arnold RM,Tattersall MH. Discussing life expectancy with terminally ill cancer patients and their carers: a qualitative study. Support Care Cancer. 2005; 13: 589–599.
  • 109
    Ray A,Block SD,Friedlander RJ,Zhang B,Maciejewski PK,Prigerson HG. Peaceful awareness in patients with advanced cancer. J Palliat Med. 2006; 9: 1359–1368.
  • 110
    Vanderwerker LC,Laff RE,Kadan-Lottick NS,McColl S,Prigerson HG. Psychiatric disorders and mental health service use among caregivers of advanced cancer patients. J Clin Oncol. 2005; 23: 6899–6907. Comment in:J Clin Oncol.2005;23:6820–6821.
  • 111
    Bambauer KZ,Zhang B,Maciejewski PK, et al. Mutuality and specificity of mental disorders in advanced cancer patients and caregivers. Soc Psychiatry Psychiatr Epidemiol. 2006; 41: 819–824.
  • 112
    Kris AE,Cherlin EJ,Prigerson H, et al. Length of hospice enrollment and subsequent depression in family caregivers: 13-month follow-up study. Am J Geriatr Psychiatry. 2006; 14: 264–269.
View Full Article (HTML) Get PDF (141K)